PHK
KRTX

Point72 Hong Kong’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Point72 Hong Kong’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-345
Closed -$78K – 1815
2022
Q3 		$78K Buy
+345
New +$69.8K ﹤0.01% 1304
2022
Q2 		– Sell
-173
Closed -$22K – 2520
2022
Q1 		$22K Sell
173
-591
-77% -$66.5K ﹤0.01% 1515
2021
Q4 		$100K Buy
764
+646
+547% +$83.5K ﹤0.01% 1178
2021
Q3 		$14K Sell
118
-819
-87% -$94.5K ﹤0.01% 1756
2021
Q2 		$107K Buy
937
+781
+501% +$91.3K ﹤0.01% 1303
2021
Q1 		$19K Buy
+156
New +$17.7K ﹤0.01% 1489
2020
Q4 		– Sell
-1,077
Closed -$83K – 2115
2020
Q3 		$83K Buy
1,077
+1,002
+1,336% +$85.4K 0.01% 594
2020
Q2 		$8K Buy
+75
New +$6.52K ﹤0.01% 1009

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's KRTX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2022, closing a stake of 345 shares — an estimated $78K sold.

Point72 Hong Kong first reported a position in KRTX in Q2 2020 and held it in 8 quarters. The position peaked at $107K in Q2 2021. 248 funds tracked by Wall St. Rank hold KRTX as of Q4 2022.

  • Point72 Hong Kong reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 345 Karuna Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $78K.
  • Point72 Hong Kong first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Point72 Hong Kong's Karuna Therapeutics, Inc. Common Stock position peaked at $107K in Q2 2021.
  • 248 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.